- call +1-201-465-4211
- email sales@mrinsights.biz
Medical contrast agent is a material used in medical imaging to improve the contrast of structure or fluids inside a body. The contrast agents provide enhanced visibility for observation of blood vessels and the gastrointestinal tract. According to the imaging modalities such as x-ray and ultrasound, an array of contrast reagents is used as per requirement of the imaging technique.
According to this study, over the next five years the Medical Contrast Agent market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Contrast Agent business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Contrast Agent market by product type, application, key manufacturers and key regions and countries.
This study considers the Medical Contrast Agent value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Other Applications
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Lantheus Medical Imaging
Nanopet Pharma
CMC Contrast
Daiichi Sankyo
Subhra Pharma Private
Spago Nanomedical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Medical Contrast Agent consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Medical Contrast Agent market by identifying its various subsegments.
Focuses on the key global Medical Contrast Agent manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Medical Contrast Agent with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Medical Contrast Agent submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Medical Contrast Agent Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Contrast Agent Consumption 2014-2024
2.1.2 Medical Contrast Agent Consumption CAGR by Region
2.2 Medical Contrast Agent Segment by Type
2.2.1 Barium-based Contrast Media
2.2.2 Iodinated Contrast Media
2.2.3 Gadolinium-based Contrast Media
2.2.4 Microbubble Contrast Media
2.3 Medical Contrast Agent Consumption by Type
2.3.1 Global Medical Contrast Agent Consumption Market Share by Type (2014-2019)
2.3.2 Global Medical Contrast Agent Revenue and Market Share by Type (2014-2019)
2.3.3 Global Medical Contrast Agent Sale Price by Type (2014-2019)
2.4 Medical Contrast Agent Segment by Application
2.4.1 Cardiovascular Disorders
2.4.2 Neurological Disorders
2.4.3 Gastrointestinal Disorders
2.4.4 Cancer
2.4.5 Nephrological Disorders
2.4.6 Musculoskeletal Disorders
2.4.7 Other Applications
2.5 Medical Contrast Agent Consumption by Application
2.5.1 Global Medical Contrast Agent Consumption Market Share by Application (2014-2019)
2.5.2 Global Medical Contrast Agent Value and Market Share by Application (2014-2019)
2.5.3 Global Medical Contrast Agent Sale Price by Application (2014-2019)
3 Global Medical Contrast Agent by Players
3.1 Global Medical Contrast Agent Sales Market Share by Players
3.1.1 Global Medical Contrast Agent Sales by Players (2017-2019)
3.1.2 Global Medical Contrast Agent Sales Market Share by Players (2017-2019)
3.2 Global Medical Contrast Agent Revenue Market Share by Players
3.2.1 Global Medical Contrast Agent Revenue by Players (2017-2019)
3.2.2 Global Medical Contrast Agent Revenue Market Share by Players (2017-2019)
3.3 Global Medical Contrast Agent Sale Price by Players
3.4 Global Medical Contrast Agent Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Medical Contrast Agent Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Medical Contrast Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Medical Contrast Agent by Regions
4.1 Medical Contrast Agent by Regions
4.1.1 Global Medical Contrast Agent Consumption by Regions
4.1.2 Global Medical Contrast Agent Value by Regions
4.2 Americas Medical Contrast Agent Consumption Growth
4.3 APAC Medical Contrast Agent Consumption Growth
4.4 Europe Medical Contrast Agent Consumption Growth
4.5 Middle East & Africa Medical Contrast Agent Consumption Growth
5 Americas
5.1 Americas Medical Contrast Agent Consumption by Countries
5.1.1 Americas Medical Contrast Agent Consumption by Countries (2014-2019)
5.1.2 Americas Medical Contrast Agent Value by Countries (2014-2019)
5.2 Americas Medical Contrast Agent Consumption by Type
5.3 Americas Medical Contrast Agent Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Medical Contrast Agent Consumption by Countries
6.1.1 APAC Medical Contrast Agent Consumption by Countries (2014-2019)
6.1.2 APAC Medical Contrast Agent Value by Countries (2014-2019)
6.2 APAC Medical Contrast Agent Consumption by Type
6.3 APAC Medical Contrast Agent Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Medical Contrast Agent by Countries
7.1.1 Europe Medical Contrast Agent Consumption by Countries (2014-2019)
7.1.2 Europe Medical Contrast Agent Value by Countries (2014-2019)
7.2 Europe Medical Contrast Agent Consumption by Type
7.3 Europe Medical Contrast Agent Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Medical Contrast Agent by Countries
8.1.1 Middle East & Africa Medical Contrast Agent Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Medical Contrast Agent Value by Countries (2014-2019)
8.2 Middle East & Africa Medical Contrast Agent Consumption by Type
8.3 Middle East & Africa Medical Contrast Agent Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Medical Contrast Agent Distributors
10.3 Medical Contrast Agent Customer
11 Global Medical Contrast Agent Market Forecast
11.1 Global Medical Contrast Agent Consumption Forecast (2019-2024)
11.2 Global Medical Contrast Agent Forecast by Regions
11.2.1 Global Medical Contrast Agent Forecast by Regions (2019-2024)
11.2.2 Global Medical Contrast Agent Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Medical Contrast Agent Forecast by Type
11.8 Global Medical Contrast Agent Forecast by Application
12 Key Players Analysis
12.1 GE Healthcare
12.1.1 Company Details
12.1.2 Medical Contrast Agent Product Offered
12.1.3 GE Healthcare Medical Contrast Agent Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 GE Healthcare News
12.2 Bayer
12.2.1 Company Details
12.2.2 Medical Contrast Agent Product Offered
12.2.3 Bayer Medical Contrast Agent Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Bayer News
12.3 Bracco Imaging
12.3.1 Company Details
12.3.2 Medical Contrast Agent Product Offered
12.3.3 Bracco Imaging Medical Contrast Agent Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Bracco Imaging News
12.4 Guerbet Group
12.4.1 Company Details
12.4.2 Medical Contrast Agent Product Offered
12.4.3 Guerbet Group Medical Contrast Agent Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Guerbet Group News
12.5 Lantheus Medical Imaging
12.5.1 Company Details
12.5.2 Medical Contrast Agent Product Offered
12.5.3 Lantheus Medical Imaging Medical Contrast Agent Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Lantheus Medical Imaging News
12.6 Nanopet Pharma
12.6.1 Company Details
12.6.2 Medical Contrast Agent Product Offered
12.6.3 Nanopet Pharma Medical Contrast Agent Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Nanopet Pharma News
12.7 CMC Contrast
12.7.1 Company Details
12.7.2 Medical Contrast Agent Product Offered
12.7.3 CMC Contrast Medical Contrast Agent Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 CMC Contrast News
12.8 Daiichi Sankyo
12.8.1 Company Details
12.8.2 Medical Contrast Agent Product Offered
12.8.3 Daiichi Sankyo Medical Contrast Agent Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Daiichi Sankyo News
12.9 Subhra Pharma Private
12.9.1 Company Details
12.9.2 Medical Contrast Agent Product Offered
12.9.3 Subhra Pharma Private Medical Contrast Agent Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Subhra Pharma Private News
12.10 Spago Nanomedical
12.10.1 Company Details
12.10.2 Medical Contrast Agent Product Offered
12.10.3 Spago Nanomedical Medical Contrast Agent Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Spago Nanomedical News
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Medical Contrast Agent
Table Product Specifications of Medical Contrast Agent
Figure Medical Contrast Agent Report Years Considered
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
